Hitch a ride to the EV boom with Blink Charging Co. (NASDAQ:BLNK)

Hitch a ride to the EV boom with Blink Charging Co. (NASDAQ:BLNK)

ByMarketFacts

Blink Charging Co. (XNAS: BLNK) provides electric vehicle (EV) charging equipment and networked EV charging services in the United States and internationally. The Company was founded in 2009 and is headquartered in Miami Beach, Florida.

Blink offers residential and commercial EV charging equipment that enable EV drivers to recharge at various location types. The company offers its services through direct sales force and resellers, as well as sells residential Level 2 chargers through various internet channels.

Invest in your future by investing in Artificial Intelligence sector

Invest in your future by investing in Artificial Intelligence sector

ByMarketFacts

Artificial Intelligence is continuously innovating our industries and changing the way we live. It is no secret that anything that attracts attention and becomes an innovation quickly penetrates the stock market.

The United States has around 2000 AI companies in total. Last year, the global artificial intelligence market was valued at $93.5 billion and is expected to grow at 38% annually through 2030.

Are Green Bonds good investment option for long term retail Investors?

Are Green Bonds good investment option for long term retail Investors?

ByMarketFacts

Green Bonds is a type of fixed income security issued to raise money for climate & environmental projects. Like any other type of bond, green bonds offer a stated return and represent a loan from an investor to a company, organization, or government agency.

Green bonds may come with tax incentives such as tax exemption and tax credits, making them a more attractive investment vs. a comparable taxable bond. Investors interested in green bonds should learn the diverse types and the pros and cons of investing before buying.

What Is Equity Research and Why Is It Important?

What Is Equity Research and Why Is It Important?

ByMarketFacts

There are many uncertainties surrounding the stock market, so investing in stocks has always been seen as a gamble. It is a common misconception in the stock market that success depends entirely on chance. A miracle may bring instant riches; a catastrophe may ruin all your hard work.

Everything is true to an extent, but equity research comes into play to protect people from the uncertainties of the stock market. Equity research acts as a timely and effective shield, ensuring the protection of investors.

With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

ByMarketFacts

Douglas Elliman Inc. (XYNS: DOUG) is a real estate company. Among other real estate-related services, it provides sales, rentals, and new development in combination with mortgages and title insurance. The company operates in two divisions: Real Estate Brokerage and Corporate and Other. The company makes revenue from Commission and other brokerage income from existing house sales, Commission and other brokerage income from development marketing, Property management income, and Title fees. 

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

ByMarketFacts

Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.

Is ESI a good opportunity for investors seeking growth: Element Solutions Inc (NYSE: ESI)?

Is ESI a good opportunity for investors seeking growth: Element Solutions Inc (NYSE: ESI)?

ByMarketFacts

Element Solutions Inc. (XYNS: ESI) is a global diversified specialty chemicals company focused on providing innovative solutions across several large and growing end-markets that enhance the products of everyday life. Developed in multi-step technological processes, the company’s innovative solutions enable the customers’ manufacturing processes in several key segments, including electronic circuitry, communication infrastructure, automotive systems, industrial surface finishing, consumer packaging, and offshore energy. With a long-standing presence in automotive markets and a deep market expertise in electronics, it sits at the intersection of this fast-growing market.

Is this solar energy stock worthy enough to be in your portfolio: Sunrun Inc.(NASDAQ: RUN)?

Is this solar energy stock worthy enough to be in your portfolio: Sunrun Inc.(NASDAQ: RUN)?

ByMarketFacts

Sunrun Inc. (XNAS: RUN) is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company was established in 2007 and is headquartered in San Francisco, California. Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media as well as its partner network. The company installs solar energy systems on its customers’ homes and provides them with the solar power produced by those systems for a 20- or 25-year initial term. It monitors, maintains, and ensures the system during the term of the contract.

Should you buy the dip now as growth resumes in Alteryx Inc (NYSE: AYX)?

Should you buy the dip now as growth resumes in Alteryx Inc (NYSE: AYX)?

ByMarketFacts

Alteryx Inc. (NYSE: AYX) is a software company that offers self-service data analytics software. By using its software platform, businesses may boost business results and business analyst productivity by significant margins. The company provides a wide range of services, including advanced analytics, location intelligence, data preparation, technological integrations, and more. Its customer base includes businesses in the financial, healthcare, retail, logistics, oil & gas, pharmaceutical, and biotech sectors. The primary source of income for the business is the licensing of its software platform to users on a subscription basis.

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

ByMarketFacts

Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.